Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. 1998

J M Lubinski, and L Wang, and A M Soulika, and R Burger, and R A Wetsel, and H Colten, and G H Cohen, and R J Eisenberg, and J D Lambris, and H M Friedman
Departments of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Many microorganisms encode proteins that interact with molecules involved in host immunity; however, few of these molecules have been proven to promote immune evasion in vivo. Herpes simplex virus type 1 (HSV-1) glycoprotein C (gC) binds complement component C3 and inhibits complement-mediated virus neutralization and lysis of infected cells in vitro. To investigate the importance of the interaction between gC and C3 in vivo, we studied the virulence of a gC-null strain in complement-intact and C3-deficient animals. Using a vaginal infection model in complement-intact guinea pigs, we showed that gC-null virus grows to lower titers and produces less severe vaginitis than wild-type or gC rescued virus, indicating a role for gC in virulence. To determine the importance of complement, studies were performed with C3-deficient guinea pigs; the results demonstrated significant increases in vaginal titers of gC-null virus, while wild-type and gC rescued viruses showed nonsignificant changes in titers. Similar findings were observed for mice where gC null virus produced significantly less disease than gC rescued virus at the skin inoculation site. Proof that C3 is important was provided by studies of C3 knockout mice, where disease scores of gC-null virus were significantly higher than in complement-intact mice. The results indicate that gC-null virus is approximately 100-fold (2 log10) less virulent that wild-type virus in animals and that gC-C3 interactions are involved in pathogenesis.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002459 Cell Fusion Fusion of somatic cells in vitro or in vivo, which results in somatic cell hybridization. Cell Fusions,Fusion, Cell,Fusions, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014709 Vero Cells A CELL LINE derived from the kidney of the African green (vervet) monkey, (CHLOROCEBUS AETHIOPS) used primarily in virus replication studies and plaque assays. Cell, Vero,Cells, Vero,Vero Cell

Related Publications

J M Lubinski, and L Wang, and A M Soulika, and R Burger, and R A Wetsel, and H Colten, and G H Cohen, and R J Eisenberg, and J D Lambris, and H M Friedman
September 2005, Vaccine,
J M Lubinski, and L Wang, and A M Soulika, and R Burger, and R A Wetsel, and H Colten, and G H Cohen, and R J Eisenberg, and J D Lambris, and H M Friedman
January 2003, Transactions of the American Clinical and Climatological Association,
J M Lubinski, and L Wang, and A M Soulika, and R Burger, and R A Wetsel, and H Colten, and G H Cohen, and R J Eisenberg, and J D Lambris, and H M Friedman
July 1983, Journal of virology,
J M Lubinski, and L Wang, and A M Soulika, and R Burger, and R A Wetsel, and H Colten, and G H Cohen, and R J Eisenberg, and J D Lambris, and H M Friedman
February 1989, Journal of virology,
J M Lubinski, and L Wang, and A M Soulika, and R Burger, and R A Wetsel, and H Colten, and G H Cohen, and R J Eisenberg, and J D Lambris, and H M Friedman
December 1982, Biochemical and biophysical research communications,
J M Lubinski, and L Wang, and A M Soulika, and R Burger, and R A Wetsel, and H Colten, and G H Cohen, and R J Eisenberg, and J D Lambris, and H M Friedman
January 1985, Journal of virology,
J M Lubinski, and L Wang, and A M Soulika, and R Burger, and R A Wetsel, and H Colten, and G H Cohen, and R J Eisenberg, and J D Lambris, and H M Friedman
August 1983, Infection and immunity,
J M Lubinski, and L Wang, and A M Soulika, and R Burger, and R A Wetsel, and H Colten, and G H Cohen, and R J Eisenberg, and J D Lambris, and H M Friedman
September 2003, Journal of immunology (Baltimore, Md. : 1950),
J M Lubinski, and L Wang, and A M Soulika, and R Burger, and R A Wetsel, and H Colten, and G H Cohen, and R J Eisenberg, and J D Lambris, and H M Friedman
January 1991, Archives of virology,
J M Lubinski, and L Wang, and A M Soulika, and R Burger, and R A Wetsel, and H Colten, and G H Cohen, and R J Eisenberg, and J D Lambris, and H M Friedman
May 2009, Journal of virology,
Copied contents to your clipboard!